Remove Advocacy Remove Clinical Trials Remove Terpenes
article thumbnail

South African Research Team Says Cannabis is ‘Very Promising’ as an Opioid Replacement

Veriheal

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. What’s more, the soon-to-be-introduced strain is laden with myrcene and beta-caryophyllene terpenes.

article thumbnail

Cannabis in Israel, with Itai Rogel

The Cannigma

I do want to say that when it comes to anxiety, sleep, I mean, what we do, for example, in Bazelet, which is quite unique, as far as oil products are concerned, this is something that is we have a lot of intellectual property on the use of terpenes in creating cannabis formulations. We have, I think, eight PhDs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ). It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 141
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. Kevin O’Leary.